Neumora Therapeutics Inc

NMRA

Equity

ISIN null / Valor 129329732

NASDAQ (2026-02-17)

USD 3.54+10.6%

Neumora Therapeutics Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Neumora Therapeutics Inc is a biotechnology firm dedicated to revolutionizing the treatment of brain diseases through innovative approaches in neuroscience. The company is at the forefront of developing medications aimed at addressing neuropsychiatric disorders and neurodegenerative diseases, which are known for their complexity and varied manifestations. Neumora's strategy involves targeting therapeutically relevant mechanisms within the central nervous system (CNS) with the goal of discovering treatments that are both novel and superior in their pharmacological effects. Additionally, the company employs a precision medicine framework to dissect the biological underpinnings of brain diseases, enabling the identification of specific patient groups who could benefit most from their therapies. This dual focus on groundbreaking pharmacology and targeted treatment approaches positions Neumora Therapeutics Inc as a key player in the quest to provide more effective solutions for conditions that have long challenged the medical community.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

103%1Y

%3Y

%5Y

Performance

99.2%1Y

142%3Y

142%5Y

Volatility

591 M

Market cap (USD)

2,287,395

Daily traded volume (Shares)

11.47 / 10.87

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

4.00

Innovation:

5.00

Society:

5.00

Nature:

1.00

Viktor Stockel

Switzerland, 27 Oct 2025

Neumora Therapeutics focuses on precision neuroscience, developing therapies for depression, anxiety, and neurological disorders. Its AI-driven approach is innovative, addressing major unmet needs in mental health. High potential, but still early-stage and volatile.

EQUITIES OF THE SAME SECTOR

QuidelOrtho Corporation